My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 92

    1.

    BMP-2 signaling in ovarian cancer and its association with poor prognosis.

    Le Page C, Puiffe ML, Meunier L, Zietarska M, de Ladurantaye M, Tonin PN, Provencher D, Mes-Masson AM.

    J Ovarian Res. 2009 Apr 14;2:4.PMID: 19366455 [PubMed - in process]Free PMC ArticleFree textRelated citations

    2.

    Patterns of expression of chromosome 17 genes in primary cultures of normal ovarian surface epithelia and epithelial ovarian cancer cell lines.

    Presneau N, Mes-Masson AM, Ge B, Provencher D, Hudson TJ, Tonin PN.

    Oncogene. 2003 Mar 13;22(10):1568-79.PMID: 12629520 [PubMed - indexed for MEDLINE]Related citations

    3.

    Microarray analysis of gene expression mirrors the biology of an ovarian cancer model.

    Tonin PN, Hudson TJ, Rodier F, Bossolasco M, Lee PD, Novak J, Manderson EN, Provencher D, Mes-Masson AM.

    Oncogene. 2001 Oct 4;20(45):6617-26.PMID: 11641787 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    4.

    Influence of monolayer, spheroid, and tumor growth conditions on chromosome 3 gene expression in tumorigenic epithelial ovarian cancer cell lines.

    Cody NA, Zietarska M, Filali-Mouhim A, Provencher DM, Mes-Masson AM, Tonin PN.

    BMC Med Genomics. 2008 Aug 7;1:34.PMID: 18687136 [PubMed]Free PMC ArticleFree textRelated citations

    5.

    Expression profiles of 290 ESTs mapped to chromosome 3 in human epithelial ovarian cancer cell lines using DNA expression oligonucleotide microarrays.

    Manderson EN, Mes-Masson AM, Novak J, Lee PD, Provencher D, Hudson TJ, Tonin PN.

    Genome Res. 2002 Jan;12(1):112-21.PMID: 11779836 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    6.

    Molecular description of a 3D in vitro model for the study of epithelial ovarian cancer (EOC).

    Zietarska M, Maugard CM, Filali-Mouhim A, Alam-Fahmy M, Tonin PN, Provencher DM, Mes-Masson AM.

    Mol Carcinog. 2007 Oct;46(10):872-85.PMID: 17455221 [PubMed - indexed for MEDLINE]Related citations

    7.

    Transcriptome analysis of serous ovarian cancers identifies differentially expressed chromosome 3 genes.

    Birch AH, Quinn MC, Filali-Mouhim A, Provencher DM, Mes-Masson AM, Tonin PN.

    Mol Carcinog. 2008 Jan;47(1):56-65.PMID: 17620309 [PubMed - indexed for MEDLINE]Related citations

    8.

    Expression of bone morphogenetic protein-2 and its receptors in epithelial ovarian cancer and their influence on the prognosis of ovarian cancer patients.

    Ma Y, Ma L, Guo Q, Zhang S.

    J Exp Clin Cancer Res. 2010 Jun 30;29:85.PMID: 20587070 [PubMed - in process]Free PMC ArticleFree textRelated citations

    9.

    Molecular genetic analysis of a cell adhesion molecule with homology to L1CAM, contactin 6, and contactin 4 candidate chromosome 3p26pter tumor suppressor genes in ovarian cancer.

    Manderson EN, Birch AH, Shen Z, Mes-Masson AM, Provencher D, Tonin PN.

    Int J Gynecol Cancer. 2009 May;19(4):513-25.PMID: 19509545 [PubMed - indexed for MEDLINE]Related citations

    10.

    Constitutive activation of BMP signalling abrogates experimental metastasis of OVCA429 cells via reduced cell adhesion.

    Shepherd TG, Mujoomdar ML, Nachtigal MW.

    J Ovarian Res. 2010 Feb 26;3:5.PMID: 20187934 [PubMed - in process]Free PMC ArticleFree textRelated citations

    11.

    Characterization of three new serous epithelial ovarian cancer cell lines.

    Ouellet V, Zietarska M, Portelance L, Lafontaine J, Madore J, Puiffe ML, Arcand SL, Shen Z, Hébert J, Tonin PN, Provencher DM, Mes-Masson AM.

    BMC Cancer. 2008 May 28;8:152.PMID: 18507860 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    12.

    VEGFR-2 silencing by small interference RNA (siRNA) suppresses LPA-induced epithelial ovarian cancer (EOC) invasion.

    Wang FQ, Barfield E, Dutta S, Pua T, Fishman DA.

    Gynecol Oncol. 2009 Dec;115(3):414-23. Epub 2009 Sep 18.PMID: 19765808 [PubMed - indexed for MEDLINE]Related citations

    13.

    [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma]

    Wang Y, Yang J, Gao Y, Zhao XL, Li HZ, Yao Z.

    Zhonghua Fu Chan Ke Za Zhi. 2009 Jul;44(7):522-8. Chinese. PMID: 19957553 [PubMed - in process]Related citations

    14.

    Expression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients.

    Wang L, Madigan MC, Chen H, Liu F, Patterson KI, Beretov J, O'Brien PM, Li Y.

    Gynecol Oncol. 2009 Aug;114(2):265-72. Epub 2009 May 17.PMID: 19450871 [PubMed - indexed for MEDLINE]Related citations

    15.

    Expression of interleukin-1 (IL-1) ligands system in the most common endometriosis-associated ovarian cancer subtypes.

    Keita M, Bessette P, Pelmus M, Ainmelk Y, Aris A.

    J Ovarian Res. 2010 Jan 28;3:3.PMID: 20181040 [PubMed - in process]Free PMC ArticleFree textRelated citations

    16.

    Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy.

    Bellone S, Siegel ER, Cocco E, Cargnelutti M, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD.

    Int J Gynecol Cancer. 2009 Jul;19(5):860-6.PMID: 19574774 [PubMed - indexed for MEDLINE]Related citations

    17.

    Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence.

    Tassi RA, Calza S, Ravaggi A, Bignotti E, Odicino FE, Tognon G, Donzelli C, Falchetti M, Rossi E, Todeschini P, Romani C, Bandiera E, Zanotti L, Pecorelli S, Santin AD.

    BMC Cancer. 2009 Jul 27;9:253.PMID: 19635143 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    18.

    Reprogramming of the transcriptome in a novel chromosome 3 transfer tumor suppressor ovarian cancer cell line model affected molecular networks that are characteristic of ovarian cancer.

    Quinn MC, Filali-Mouhim A, Provencher DM, Mes-Masson AM, Tonin PN.

    Mol Carcinog. 2009 Jul;48(7):648-61.PMID: 19123201 [PubMed - indexed for MEDLINE]Related citations

    19.

    KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells.

    Kim KH, Xie Y, Tytler EM, Woessner R, Mor G, Alvero AB.

    J Transl Med. 2009 Jul 20;7:63.PMID: 19619321 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    20.

    Comparative proteome analysis of human epithelial ovarian cancer.

    Gagné JP, Ethier C, Gagné P, Mercier G, Bonicalzi ME, Mes-Masson AM, Droit A, Winstall E, Isabelle M, Poirier GG.

    Proteome Sci. 2007 Sep 24;5:16.PMID: 17892554 [PubMed - in process]Free PMC ArticleFree textRelated citations

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...
    You are here: NCBI > Literature > PubMed
    Write to the Help Desk